Kestra Medical Technologies, Ltd.
KMTS
$24.15
$0.391.64%
NASDAQ
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 12.41% | 14.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.41% | 14.20% | |||
| Cost of Revenue | 9.58% | 12.37% | |||
| Gross Profit | 15.96% | 16.59% | |||
| SG&A Expenses | -33.16% | 112.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.28% | 83.37% | |||
| Operating Income | 40.10% | -134.03% | |||
| Income Before Tax | 49.43% | -134.62% | |||
| Income Tax Expenses | -67.65% | 466.67% | |||
| Earnings from Continuing Operations | 49.47% | -134.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -476.80% | |||
| Net Income | 50.39% | -142.01% | |||
| EBIT | 40.10% | -134.03% | |||
| EBITDA | 42.10% | -147.83% | |||
| EPS Basic | 77.64% | -80.27% | |||
| Normalized Basic EPS | 76.47% | -99.03% | |||
| EPS Diluted | 77.64% | -80.27% | |||
| Normalized Diluted EPS | 76.47% | -99.03% | |||
| Average Basic Shares Outstanding | 108.69% | 23.63% | |||
| Average Diluted Shares Outstanding | 108.69% | 23.63% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||